TODD STRATEGY GROUP

Lobbying for TAKEDA PHARMACEUTICALS AMERICA, INC. · Pharmaceutical company.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · $50,000.00 income · posted Apr 20, 2026

Bills named in this filing 1

Lobbying activity 2

Health Issues

Rare Disease Issues. H.R.4299: Protecting Patient Access to Cancer and Complex Therapies Act.

Medicare/Medicaid

General Medicare/Medicaid Issues. Implementation of Inflation Reduction Act of 2022.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.